Database Query Results : Acoschimperoside P, 2’-acetate, ,

Aco, Acoschimperoside P, 2’-acetate: Click to Expand ⟱
Features: cardiac glycoside

Acoschimperoside P, 2′-acetate — a plant-derived cardiac glycoside (cardenolide-type glycoside) reported as a Hedgehog (Hh) pathway inhibitor and cytotoxic small molecule in human cancer cell lines. It is a natural product isolated from Vallaris glabra (leaves) and was characterized with full NMR assignments in the discovery report. Standard abbreviations are not established in the literature; it is typically referenced by its full name.

Primary mechanisms (ranked):

  1. Hedgehog pathway inhibition via suppression of GLI-dependent transcriptional output
  2. Downstream reduction of GLI-related target proteins (reported PTCH and BCL-2 decreases)
  3. Cytotoxicity/antiproliferative activity in cancer cells (phenotypic outcome; upstream trigger not fully resolved)

Bioavailability / PK relevance: No human PK or clinical formulation data were identified in primary sources. As a highly oxygenated glycoside (cardiac glycoside-like), systemic exposure and oral bioavailability are uncertain and may be limited; translation would likely require dedicated PK/PD work and safety characterization typical for cardenolide-class agents.

In-vitro vs systemic exposure relevance: Reported pathway/cytotoxic effects are in vitro at micromolar-range concentrations; whether such exposures are achievable safely in vivo is unknown without PK data.

Clinical evidence status: Preclinical only (cell-based assays). No registered therapeutic clinical trials or regulatory status identified.

Acoschimperoside P, 2′-acetate is a natural glycoside with promising anticancer potential based on early-stage research that indicates possible induction of apoptosis, cell cycle arrest, and modulation of key signaling pathways (e.g., MAPK/ERK and PI3K/Akt). However, its pathways of action and overall clinical utility remain exploratory.

Strong cytotoxicity against human pancreatic and human prostate cancer.
Acoschimperoside is a naturally occurring glycoside that has gained interest due to its potential therapeutic properties, including anticancer effects. Glycosides are compounds in which a sugar molecule (glycone) is linked to a non-sugar moiety (aglycone). In the case of acoschimperoside, the specific sugar–aglycone combination contributes to its bioactivity.
• As a glycoside, acoschimperoside consists of a sugar moiety attached to a non-carbohydrate component. This structural motif is common among many plant-derived compounds that exhibit various pharmacological activities.
The sugar portion can influence the solubility, bioavailability, and even the targeting mechanism of the molecule within biological systems. The aglycone, on the other hand, frequently contributes to the molecule’s direct bioactivity, such as modulating signaling pathways involved in cell survival, apoptosis, or inflammation.
Similar glycosides have been studied for their effects on pathways like apoptosis (programmed cell death), cell cycle regulation, and inhibition of survival pathways (such as PI3K/AKT/mTOR and NF‑κB signaling).

Mechanistic pathway ranking for Acoschimperoside P, 2′-acetate

Rank Pathway / Axis Cancer Cells Normal Cells TSF Primary Effect Notes / Interpretation
1 Hedgehog signaling output ↓ GLI-pathway activity (model-dependent) Unclear Pathway inhibition Identified as active in a Hedgehog signaling inhibition assay; broader target engagement upstream of GLI is not fully defined in primary reports.
2 GLI target gene/protein program ↓ PTCH; ↓ BCL-2 (dose-dependent) Unclear Downstream transcriptional program suppression Reported decreases in GLI-related proteins including PTCH and BCL-2; interpret as reduced Hh/GLI output rather than direct BCL-2 targeting.
3 Cell viability and proliferation ↓ Viability in PANC1 and DU145 (dose-dependent) Unclear Cytotoxic/antiproliferative phenotype Strong cytotoxicity reported in vitro; selectivity window vs non-malignant cells was not established in the key primary paper.
4 Na+/K+-ATPase axis Unclear (context-dependent) Unclear (context-dependent) Putative class-related mechanism Compound is described as a cardiac glycoside; many cardenolides engage Na+/K+-ATPase, but this was not directly demonstrated for this specific molecule in the primary Hedgehog-focused report.
5 Clinical Translation Constraint Micromolar in-vitro activity; no in-vivo efficacy/PK established Potential narrow safety margin (class concern) Translation risk Key constraints are absent PK, unknown therapeutic index, and typical cardiac glycoside safety liabilities; requires dedicated in-vivo PK/PD + tox before interpretation as a viable lead.


Scientific Papers found: Click to Expand⟱
1- Aco,    Acoschimperoside P, 2'-acetate: a Hedgehog signaling inhibitory constituent from Vallaris glabra
- in-vitro, PC, PANC1 - in-vitro, Pca, DU145
HH↓, PTCH1↓, Bcl-2↓, Gli1↓,

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Cell Death ⓘ

Bcl-2↓, 1,  

Proliferation, Differentiation & Cell State ⓘ

Gli1↓, 1,   HH↓, 1,   PTCH1↓, 1,  
Total Targets: 4

Pathway results for Effect on Normal Cells:


Total Targets: 0

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:24  Target#:%  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page